| DC67139 |
TFM-4AS-1
Featured
|
TFM-4AS-1 is a selective androgen receptor modulator (SARM), and a potent androgen receptor (AR) ligand with an IC50 of 38 nM. TFM-4AS-1 is a gene-selective agonist. |
|
| DC67140 |
LG-121071
Featured
|
LG-121071 is an orally active and selective androgen receptor modulator with a Ki of 17 nM. |
|
| DC67141 |
S-40503
Featured
|
S-40503 is an orally active and selective androgen receptor modulator. S-40503 significantly increases the bone mineral density (BMD) and biomechanical strength of femoral cortical bone. |
|
| DC67142 |
5-Chloroisoquinoline
Featured
|
5-Chloroisoquinoline (compound 42) is an inhibitor of SARM1 (Sterile alpha and toll/interleukin receptor (TIR) motif containing protein 1), an enzyme involved in axon degeneration that catalyzes multiple activities through a ternary complex mechanism. 5-Chloroisoquinoline can be used in the study of neurodegenerative diseases or axon degeneration. |
|
| DC67143 |
(+)-JNJ-37654032
Featured
|
(+)-JNJ-37654032 is an orally active and selective androgen receptor modulator. (+)-JNJ-37654032 can be used in the study of muscle-wasting diseases. |
|
| DC67144 |
Phenazopyridine
Featured
|
Phenazopyridine is a competitive SARM1 inhibitor, with IC50 145 μM. Phenazopyridine is a TRPM8 antagonist. Phenazopyridine has a local anesthetic/analgesic effect. Phenazopyridine is used to relieve painful symptoms of conditions such as cystitis and urethritis. Phenazopyridine can promote neuronal differentiation and can also be used in the study of traumatic brain injury, peripheral neuropathy and neurodegenerative diseases. |
|
| DC67145 |
2-Amino-5-methylhexane
Featured
|
|
|
| DC67146 |
YK11
Featured
|
|
|
| DC67147 |
N-Methyl-p-tyramine Hydrochloride
Featured
|
N-Methyltyramine (hydrochloride) can be isolated from the plants of the Citrus genus. |
|
| DC67148 |
4-Nitro-3-(trifluoromethyl)aniline
Featured
|
4-Nitro-3-(trifluoromethyl)aniline is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
|
| DC67149 |
DL-N-Isopropyloctopamine
Featured
|
|
|
| DC67150 |
(2R)-3-Bromo-2-hydroxy-2-methylpropanoic acid
Featured
|
|
|
| DC67151 |
2-Chloro-4-fluoro-3-methylbenzonitrile
Featured
|
|
|
| DC67152 |
Octopamine
Featured
|
Octopamine is an alpha-adrenergic sympathomimetic amine biosynthesized from tyramine. Octopamine may be found in the CNS, platelets, and in invertebrate nervous systems. It is used to treat hypotension and may acy as a cardiotonic. |
|
| DC67153 |
5-nitrothiophene-2-carbaldehyde
Featured
|
|
|
| DC67154 |
OTE-AC
Featured
|
|
|
| DC67155 |
3-(dibenzo[b,d]furan-4-yl)phenyl)boronic acid
Featured
|
|
|
| DC67156 |
tert-Butyl 3-formylpyrrolidine-1-carboxylate
Featured
|
tert-Butyl 3-formylpyrrolidine-1-carboxylate is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
|
| DC67157 |
Dibenzo[b,d]furan-1-ylboronicacid
Featured
|
|
|
| DC67158 |
ANTHRACENE, 9-[1,1'-BIPHENYL]-2-YL-
Featured
|
|
|
| DC67159 |
Thioxanthen-9-one
Featured
|
|
|
| DC67160 |
1-Bromodibenzofuran
Featured
|
|
|
| DC60703 |
164A10
Featured
|
164A10 is a potent and effective Pin1 degrader with IC50 of 4.1 nM in DELFIA displacement assay with significantly improved properties over the parent molecule BJP-07-017-3. |
|
| DC60704 |
158H9
Featured
|
158H9 is a potent and effective Pin1 degrader with IC50 of 21.4 nM in DELFIA displacement assay with significantly improved properties over the parent molecule BJP-07-017-3. |
|
| DC60705 |
Lipid FO-32
Featured
|
FO-32 is an artificial intelligence-guided designed ionizable lipid for RNA delivery to the muscle, lung and nose. FO-32 LNPs enable potent transfection throughout the whole ferret lung epithelium, from trachea to alveoli. |
|
| A758 |
Ibritumomab
Featured
|
|
|
| A759 |
Regeneron patent anti-CD20
Featured
|
|
|
| A760 |
Samalizumab
Featured
|
Samalizumab (ALXN 6000) is a humanized monoclonal antibody that specifically binds to CD200 and blocks its ligation to the CD200 receptor (CD200R). Samalizumab can be used for multiple myeloma and B-cell chronic lymphocytic leukemia research. |
|
| A761 |
FR104
Featured
|
|
|
| A762 |
Lulizumab
Featured
|
Lulizumab (Humanized Anti-CD28 Recombinant Antibody) is a selective CD28 blockade, Lulizumab prevents T cell activation by selectively targeting CD28 signaling. |
|
